SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 18, 15:45
356.35
6.55 (1.87%)
VOLUME 93,360
LIVE
NSE
Jan 18, 15:53
356.40
6.8 (1.95%)
VOLUME 1,051,575
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Zydus receives final approval from USFDA for Methotrexate tablets USP

3.16 pm | 18 Jan 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lympho...

Stocks in news: Idea, Rel Cap, IDFC, Panacea, ICICI Pru, Cadila 

8.00 am | 18 Jan 2017 |  Source: CNBC-TV18

Bharti Airtel | Idea Cellular | Hindustan Zinc | IDFC | Reliance Capital | Mercator | Panacea Biotec | ICICI Prudential | ABG Shipyard | Cadila Health...

Cadila settles patent litigation related to Livalo tablets

2.20 pm | 17 Jan 2017 |  Source: PTI

The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Kowa Company, Kowa Pharmaceuticals America Inc and N...

Zydus announces settlement with Kowa Company

1.46 pm | 17 Jan 2017 |  Source: Moneycontrol.com

Cadila Healthcare and its subsidiary Zydus Pharmaceuticals have finalized an agreement with Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and...

Cadila Q3 PAT seen up 8.7% to Rs 390.3 cr: ICICI Securities

2.22 pm | 14 Jan 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 7.1 percent Q-o-Q (up 4.9 percent Y-o-Y) to Rs 2535.1 crore, according to ICICI Securities....

Q3 results: Five trends to watch out from Indian drugmakers

2.00 pm | 14 Jan 2017 |  Source: Moneycontrol.com

Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounde...

Cadila settles patent litigation related to anti-seizure drug

1.56 pm | 13 Jan 2017 |  Source: PTI

The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Upsher-Smith Laboratories, Inc to settle all outstan...

Cadila Healthcare Q3 PAT seen up 9.5% to Rs 369.6 cr: KR Choksey

12.29 pm | 13 Jan 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 7.5 percent Q-o-Q (up 7.3 percent Y-o-Y) to Rs 2512.6 crore, according to KR Choksey....

Pharma falls on Trump's comments, analysts say impact unlikely

11.05 am | 12 Jan 2017 |  Source: Moneycontrol.com

Shares of Sun Pharma, Dr Reddy's Labs and Cadila were down dragging the index almost 1 percent from previous close. Major Indian pharma companies earn...

Indian drug market growth moderates to 7.2% in December

8.18 pm | 09 Jan 2017 |  Source: Moneycontrol.com

The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic portfolio a...

Buy, sell, hold: 11 stocks that analysts are watching out today

8.40 am | 09 Jan 2017 |  Source: Moneycontrol.com

Nomura has a buy ratings on Dr Reddy’s, Glenmark, Alkem, Cadila and Jubilant Life. It says Teva’s 2017 guidanceis lower than what was presented i...

Cadila Healthcare's Q3 results on January 31, 2017

12.01 pm | 05 Jan 2017 |  Source: Moneycontrol.com

Cadila Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on January 31, 2017 to consider inter al...

Enter Cadila Healthcare at around Rs 330-340: Prakash Gaba 

3.16 pm | 02 Jan 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com suggests buying Cadila Healthcare at around Rs 330-340. ...

Buy, sell, hold: 6 stocks to watch out on 2016 last trading day

8.22 am | 30 Dec 2016 |  Source: Moneycontrol.com

Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddy’s and Cadila. It says trailing three-month sales declined sequentially for T...

Sell Divis Labs, Cadila Health, Adani Ports: CA Rudramurthy BV 

12.41 pm | 29 Dec 2016 |  Source: CNBC-TV18

CA Rudramurthy BV, Research head at Vachana Investments recommends selling Divis Labs, Cadila Healthcare and Adani Ports....

Buy M&M Financial, Mindtree; sell Cadila Health: Ashwani Gujral 

11.05 am | 29 Dec 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com suggests buying Cholamandalam Investment, M&M Financial Services and Mindtree and advises selling Cadila Healthcar...

Stocks in news: Goa Carbon, IRB Infra, JMC Projects, JK Tyre 

8.00 am | 29 Dec 2016 |  Source: Moneycontrol.com

Goa Carbon | Cadila Healthcare | IRB Infrastructure | Vindhya Telelinks | JK Tyre | JMC Projects | Prathiba Industries | Sastasundar Ventures | Phoeni...

Zydus recalls over 16k bottles of anti-depressant drug in US

6.22 pm | 28 Dec 2016 |  Source: PTI

Zydus Pharmaceuticals USA Inc is recalling over 16 thousand bottles of Bupropion Hydrochloride tablets manufactured by Ahmedabad-based Cadila Healthca...

Sell Hindalco, Cadila, UltraTech; buy Mindtree, BEL: Gujral 

9.54 am | 23 Dec 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one may sell Hindalco Industries, Cadila Healthcare and UltraTech Cement and buy Mindtree and ...

Stocks in news: Tata Steel, Divis Labs, IVRCL, Prestige Estate 

8.00 am | 08 Dec 2016 |  Source: CNBC-TV18

Tata Steel | Adani Ports | Divis Labs | Crompton Greaves | Prestige Estates | PNC Infra | Polaris | Phoenix Mills | Gujarat Ambuja Exports | eClerx | ...

1 2 3 4
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.